Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Neumann

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Biochemistry|March 17, 2004
Mistletoe lectin I is a sialic acid-specific lectin with strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal beta 1-4GlcNAc residuesJohannes Müthing, Iris Meisen, Patrick Bulau, et al.
Journal of Medical Economics|October 3, 2024
Public sector replacement of privately funded pharmaceutical R&D: cost and efficiency considerationsDavid Proudman, Urvi Desai, Dumingu Aparna Gomes, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|July 5, 2023
Collaborative Uncertainty Benefits Multi-Agent Multi-Modal Trajectory ForecastingBohan Tang, Yiqi Zhong, Chenxin Xu, et al.
Anatomy and Embryology|June 13, 2003
Lectin histochemistry of the lymphoid organs of the chickenJulia Jörns, Ulrich Mangold, Ulrich Neumann, et al.
Glycobiology|July 30, 2002
Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosidesJohannes Müthing, Monika Burg, Babette Möckel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 3, 2004
Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscuminJohannes Müthing, Iris Meisen, Bernhard Kniep, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Biochemistry|March 17, 2004
Mistletoe lectin I is a sialic acid-specific lectin with strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal beta 1-4GlcNAc residuesJohannes Müthing, Iris Meisen, Patrick Bulau, et al.
Journal of Medical Economics|October 3, 2024
Public sector replacement of privately funded pharmaceutical R&D: cost and efficiency considerationsDavid Proudman, Urvi Desai, Dumingu Aparna Gomes, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|July 5, 2023
Collaborative Uncertainty Benefits Multi-Agent Multi-Modal Trajectory ForecastingBohan Tang, Yiqi Zhong, Chenxin Xu, et al.
Anatomy and Embryology|June 13, 2003
Lectin histochemistry of the lymphoid organs of the chickenJulia Jörns, Ulrich Mangold, Ulrich Neumann, et al.
Glycobiology|July 30, 2002
Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosidesJohannes Müthing, Monika Burg, Babette Möckel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 3, 2004
Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscuminJohannes Müthing, Iris Meisen, Bernhard Kniep, et al.
Pageof 3